SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-14-187427
Filing Date
2014-05-07
Accepted
2014-05-07 16:06:30
Documents
11
Period of Report
2014-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d703338d10q.htm 10-Q 488375
2 EX-31.1 d703338dex311.htm EX-31.1 6392
3 EX-31.2 d703338dex312.htm EX-31.2 6396
4 EX-32.1 d703338dex321.htm EX-32.1 3266
5 EX-32.2 d703338dex322.htm EX-32.2 3256
  Complete submission text file 0001193125-14-187427.txt   5016282

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT hptx-20140331.xml EX-101.INS 746761
7 XBRL TAXONOMY EXTENSION SCHEMA hptx-20140331.xsd EX-101.SCH 48340
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE hptx-20140331_cal.xml EX-101.CAL 65519
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE hptx-20140331_def.xml EX-101.DEF 157508
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE hptx-20140331_lab.xml EX-101.LAB 407156
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE hptx-20140331_pre.xml EX-101.PRE 275885
Mailing Address 2000 SIERRA POINT PARKWAY SUITE 400 BRISBANE CA 94005
Business Address 2000 SIERRA POINT PARKWAY SUITE 400 BRISBANE CA 94005 650-745-7802
HYPERION THERAPEUTICS INC (Filer) CIK: 0001386858 (see all company filings)

IRS No.: 611512713 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35614 | Film No.: 14820964
SIC: 2834 Pharmaceutical Preparations